X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274
https://www.koreabiomed.com/news/articleView.html?idxno=21928#:~:text=It%20is%20the%20first%20case,to%20improve%20the%20square%20jaw
https://www.globenewswire.com//news-release/2023/08/24/2731078/0/en/AEON-Biopharma-Receives-Notice-of-Allowance-from-USPTO-for-a-Patent-Covering-Use-of-Botulinum-Toxins-to-Treat-Migraine-Headache.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274
https://www.fiercebiotech.com/biotech/aeon-looks-launch-phase-3-after-boto-treatment-hits-phase-2-goals-rare-neurologic-disorder
https://www.fiercepharma.com/pharma/ironing-out-delivery-wrinkles-galderma-posts-phase-3-wins-liquid-botulinum-toxin-route-fda
https://www.prnewswire.com/news-releases/delnova-to-advance-revivox-a-groundbreaking-rescue-drug-to-reverse-botulinum-toxin-neuromodulator-complications-301515854.html
https://www.prnewswire.com/news-releases/aquavit-files-ind-with-fda-for-dtx-021-a-new-botulinum-toxin-301510523.html
https://www.fiercepharma.com/pharma/evolus-neurotoxin-jeuveau-gives-company-something-smile-about-2021-sales-swell-76
https://www.prnewswire.com/news-releases/healis-therapeutics-acquires-ownership-of-key-botulinum-toxin-patent-301479416.html
https://www.pharmacompass.com/pdf/news/eirion-therapeutics-announces-strategic-agreement-for-htl-biotechnology-1632308263.pdf
https://www.prnewswire.com/news-releases/galderma-announces-top-line-results-from-phase-2-clinical-dose-escalating-study-with-azzalure--dysport-abobotulinumtoxina-301174187.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103000
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103000
https://www.biospace.com/article/releases/ipsen-announces-updated-indication-for-dysport-abobotulinumtoxina-for-the-treatment-of-spasticity-in-children/
http://www.koreabiomed.com/news/articleView.html?idxno=8313
http://www.koreaherald.com/view.php?ud=20200418000083
http://www.pharmatimes.com/news/botox_gets_license_update_in_uk_1330105
http://www.pharmatimes.com/news/mhra_updates_dysport_license_to_include_upper_limb_spasticity_in_children_1321570
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274
https://www.biospace.com/article/ipsen-s-dysport-successful-in-phase-iiib-iv-trial-for-limb-spasticity/
http://www.pmlive.com/pharma_news/abbvieallergans_merger_faces_public_opposition_1301551
https://www.fiercepharma.com/pharma/both-a-history-for-anticompetitive-conduct-abbvie-and-allergan-should-get-close-scrutiny-at
https://www.prnewswire.com/news-releases/fda-approves-us-worldmeds-myobloc-rimabotulinumtoxinb-injection-for-chronic-sialorrhea-300906932.html
https://www.fiercepharma.com/manufacturing/whoops-allergan-s-bid-to-shield-botox-manufacturing-secrets-from-competitors
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-daewoong-evolus-botox-rival-surprise-fda-visits-daiichi-s-cancer-nod
Market Place
Share 
